Alprostadil lyophilized liposomal
Alternative Names: Prostaglandin E1 lyophilized liposomalLatest Information Update: 23 Sep 2021
At a glance
- Originator BioSphere Technologies; Harvard Scientific Corporation
- Developer BioSphere Technologies; Harvard Scientific Corporation; Sae Han Pharmaceuticals
- Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction; Female sexual dysfunction; Male sexual dysfunction; Psoriasis
Most Recent Events
- 02 Oct 2001 No-Development-Reported for Erectile dysfunction in European Union (Intrameatal)
- 02 Oct 2001 No-Development-Reported for Erectile dysfunction in South Korea (Intrameatal)
- 02 Oct 2001 No-Development-Reported for Erectile dysfunction in USA (Intrameatal)